Jazz Pharmaceuticals plc — Director's Dealing 2015

May 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-05-12

Reporting Person: O'Keefe Kenneth W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-12	Ordinary Shares	M	4500.0	$46.83	Acquired	10650	Direct
2015-05-12	Ordinary Shares	S	1218.0	$174.8978	Disposed	9432	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-12	Non-Qualified Stock Option (right to buy)	$46.83	M	4500.0	Disposed	2022-08-08	Ordinary Shares (4500)	Direct

Footnotes

F1: The ordinary shares subject to this option fully vested as of August 9, 2013.